Visit LathamDrive – A new site with resources to help emerging companies grow.

Phillip S. Stoup

San Francisco
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA

Phillip Stoup advises companies, investment banks, and private equity firms in capital markets transactions particularly in the life sciences and technology sectors.

Mr. Stoup represents issuers, underwriters, and initial purchasers on a range of transactions, including:

  • Initial public offerings (IPOs)
  • Follow-on and secondary offerings
  • Registered and 144A convertible debt offerings
  • Private placements of public equity (PIPEs)
  • Acquisition financing
  • Strategic investments

He also advises companies on securities law compliance and general corporate governance matters.

Mr. Stoup draws on experience with robust deal flow — he has advised on billions of dollars' worth of financings — and a global perspective gained from six years resident in Latham’s London office.

Mr. Stoup has worked with the following companies, representing them in initial public offerings, venture financings, as well as advising them on legal and business matters:

  • 4D Molecular Therapeutics
  • Bloom Energy
  • Cloudera
  • Coherus BioSciences
  • Corsair Gaming
  • Eargo
  • Nevro
  • Planet Labs
  • Postmates
  • Restoration Robotics

He has represented the underwriters on IPOs and follow-on offerings for the following:

  • AveXis
  • Allogene
  • BridgeBio
  • Kronos Bio
  • MyoCardia
  • Silverback Therapeutics

Mr. Stoup also regularly advises investment banks, including the following, on offerings for life sciences and technologies companies:

  • BofA Merrill Lynch
  • Citigroup
  • Cowen and Company
  • Credit Suisse
  • Goldman Sachs
  • Jefferies
  • J.P. Morgan
  • Leerink Partners
  • Morgan Stanley
  • RBC Capital
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.